Search research articles

Related Concept Videos

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Home
Tumor-educated Platelets In Lung Cancer.

Home
Tumor-educated Platelets In Lung Cancer.

Related Experiment Video

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

Tumor-educated platelets in lung cancer.

Md Sadique Hussain¹, Ehssan Moglad², Ahsas Goyal³

¹Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India.

Clinica Chimica Acta; International Journal of Clinical Chemistry

|April 14, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

Tumor-educated platelets (TEPs) offer a novel, non-invasive method for lung cancer (LC) diagnosis and monitoring. Analyzing platelet RNA profiles can detect LC, predict treatment responses, and guide personalized therapies.

Keywords:

Liquid biopsy Lung cancer Non-invasive diagnostics Platelet transcriptome RNA biomarkers

More Related Videos

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

Related Experiment Videos

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

Area of Science:

Oncology
Molecular Diagnostics
Biomarker Discovery

Background:

Lung cancer (LC) remains a leading cause of cancer mortality globally.
Non-invasive diagnostic and monitoring techniques are crucial for effective LC treatment.
Tumor-educated platelets (TEPs) are emerging biomarkers with potential for comprehensive tumor insights.

Purpose of the Study:

To review the role of TEPs in understanding tumor biology, metastasis, and treatment response in lung cancer.
To highlight the diagnostic and prognostic capabilities of analyzing RNA within TEPs.
To discuss the integration of advanced technologies for improving TEP-based diagnostics.

Main Methods:

Review of current literature on platelet-tumor interactions and TEP biomarker applications.

Analysis of RNA sequencing data from TEPs for LC detection and molecular profiling (EGFR, KRAS, ALK).

Exploration of TEPs' utility in predicting responses to immunotherapy and targeted therapy.

Main Results:

TEPs exhibit active RNA profiles influenced by tumor microenvironments, providing insights into cancer biology.
Platelet RNA analysis demonstrates high accuracy in detecting LC and identifying specific oncogenic alterations.
TEP-based RNA profiling shows promise for predicting treatment efficacy, particularly in immunotherapy and targeted therapy.

Conclusions:

TEPs represent a groundbreaking, non-invasive approach for lung cancer diagnostics and therapeutic monitoring.
Further standardization of TEP extraction and purification methods is necessary for clinical translation.
Combining TEPs with other biomarkers like ctDNA and exosomal RNA can enhance early-stage LC diagnosis and personalized treatment strategies.